Las Vegas, NV -- (SBWIRE) -- 10/18/2012 -- Beststocksdaily is one of leading U.S. stock update providers to valued investors. Following are the notable volume movers as reported by http://beststocksdaily.com/
Cypress Semiconductor Corporation (NASDAQ:CY) is currently trading at $10.10, 7.93% lower. The company third-quarter profit sank 64% as revenue slipped substantially. The company posted a profit of $14.3 million, or nine cents a share, down from $40 million, or 22 cents a share, a year earlier. Excluding stock-based compensation, acquisition-related charges and other items, adjusted earnings fell to 20 cents a share from 37 cents. Revenue slumped 23% to $203 million.
Analysts polled by Thomson Reuters most recently expected 20 cents a share in adjusted earnings and $202 million in revenue.
To Get complete technical analysis on CY go to http://beststocksdaily.com/p2/index.php?company=CY
Boston Scientific Corporation (NYSE:BSX) fell 2.85% to $5.46. For its third quarter, Boston Scientific reported a loss of $725 million, or 52 cents a share, compared with a year-earlier profit of 142 million, or nine cents a share. Revenue decreased 7% to $1.74 billion, or 5% excluding currency fluctuations and divestitures.
Can BSX Continue to Fall? Find Out Here http://beststocksdaily.com/p2/index.php?company=BSX
USG Corporation (NYSE:USG) jumped 5.32% to $23.94. The company third-quarter loss narrowed as the building-products company's margins and revenue improved. USG reported a loss of $29 million, or 28 cents a share, compared with a loss of $115 million, or $1.09 a share, a year earlier. The per-share loss from continuing operations was 29 cents compared with $1.11 a year ago. Sales rose 8.5% to $828 million.
Analysts polled by Thomson Reuters had most recently forecast a loss of 10 cents on revenue of $867 million.
To Get complete technical analysis on USG go to http://beststocksdaily.com/p2/index.php?company=USG
CytRx Corporation (NASDAQ:CYTR) among the losers and the stock fell 19.29% to $2.51. The company sale of 8 million of its shares priced at a 20% discount to Wednesday's close, sending the stock sharply lower. The company is raising funds for clinical development of two of its drug candidates and for other purposes
Get Free Trend Analysis on CYTR Here http://beststocksdaily.com/p2/index.php?company=CYTR
Beststocksdaily’s team is engaged in providing valuable and updated news information on U.S. stocks on a regular basis. Beststocksdaily’s instant stock news on Major Gainers, small cap penny stocks and various other stocks, guides investors in making the wise stock market investments decision. To Get Instant updates in the inbox, readers are advised to sign up for free at Beststocksdaily.com.
The assembled information disseminated by beststocksdaily.com is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. beststocksdaily.com does expect that investors will buy and sell securities based on information assembled and presented in beststocksdaily.com. PLEASE always do your own due diligence, and consult your financial advisor.
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)